(167 days)
No
The description focuses on RFID technology for counting and locating items, with no mention of AI or ML algorithms for analysis or decision-making.
No.
This device is designed for counting and detecting retained surgical items, which is a safety and management tool during surgery, not a device that treats or diagnoses a disease or condition in a patient.
No
Explanation: The device is described as an RFID system for counting surgical items and detecting retained RFID-tagged items. While it identifies the presence of objects, it does not analyze biological samples, physiological functions, or images to provide a diagnosis of a disease or condition. Its function is to prevent an error (retained surgical items), not to diagnose a medical state.
No
The device description explicitly states the system includes hardware components such as a cart and antennas, in addition to software.
Based on the provided information, the ORLocate™ system is not an In Vitro Diagnostic (IVD) device.
Here's why:
- IVD Definition: In Vitro Diagnostics are devices intended for use in the collection, preparation, and examination of specimens taken from the human body (such as blood, urine, or tissue) to provide information for the diagnosis, treatment, or prevention of disease.
- ORLocate™ Intended Use: The ORLocate™ system's intended use is focused on counting and detecting surgical items (sponges, towels, instruments) within a surgical site during surgical procedures. It is an adjunctive method to prevent retained surgical items.
- No Specimen Analysis: The system does not involve the collection, preparation, or analysis of any biological specimens from the human body. It interacts with RFID-tagged items and the surgical site itself.
Therefore, the ORLocate™ system falls under the category of a surgical device or system used in the operating room environment, not an IVD.
N/A
Intended Use / Indications for Use
The ORLocate™ system is indicated for use in recording and counting the number of RFID-tagged surgical sponges, laparotomy sponges, towels and other tagged items used during surgical procedures in which counting is required. In addition, the product is indicated for providing a non-invasive means of detecting retained RFID-tagged surgical sponges, towels and other tagged items within a surgical site, as an adjunctive detection method to current surgical counting systems and methods.
Product codes
LWH, GDY
Device Description
Haldor ORLocate™ system is an RFID system providing a solution that enables the enumeration of sponges and surgical manual instruments, utilizing passive tags for keeping track of the items during surgery and to identify counting problems. In addition, the system provides a non-invasive means of locating retained surgical items within a surgical site.
The submission consists of the ORLocate™ system which includes: cart and antennas. Additionaly the submission includes accessories which are: associated single use surgical sponges, gauzes, pads and surgical towels each fitted with a uniquely coded RFID tag and uniquely coded RFID tag used for surgical instruments. The RF frequency the system uses is 13.56 MHz according to ISO 15693.
The system supplies also a semi-automatic application to help in counting untagged items, the count information is first entered manually and the calculations are automatic.
From this point on the system cart and antennas will be referred to as the "ORLocate™ system," sponges fitted with Haldor RFID tag will be referred to as "RFID tagged sponge" or "RFID tagged item" and a manual surgical instrument fitted with Haldor RFID tag will be referred to as "RFID tagged surgical instrument" or "RFID tagged item" too.
The system detects each RFID tagged item placed on top of the system antennas prior to surgery and creates an inventory of all sponges (e.g. gauzes, pads) and instruments. The user can also register new items during surgery and the inventory is updated automatically after the new items are scanned in an RFID antenna. The system performs automatic count of all inventory every 5 minutes and also performs count upon user request.
At the end of the procedure, final counts are provided by the system and in the case that any items are missing the mobile antenna may be used to search the surgical site for the retained RFID tagged item.
Mentions image processing
Not Found
Mentions AI, DNN, or ML
Not Found
Input Imaging Modality
Not Found
Anatomical Site
surgical site
Indicated Patient Age Range
Not Found
Intended User / Care Setting
Not Found
Description of the training set, sample size, data source, and annotation protocol
Not Found
Description of the test set, sample size, data source, and annotation protocol
Not Found
Summary of Performance Studies (study type, sample size, AUC, MRMC, standalone performance, key results)
Non-clinical testing included demonstrating performance of system and tagged items in laboratory tests. Tests demonstrated biocompatibility of tagged items, and permanent attachment of the tags to both sponges and instruments. The validated software functioned as intended under simulated use, properly counting sponges in body fluids. Test results also demonstrate the RFID tagged sponges and instruments are as safe as the predicate devices and the software installed on the system cart computer provides an added measure of safety and effectiveness to current methods of sponge and instrument counting presently used in the surgical and clinical environments. Pertinent testing done on this device include: system interference with operating room devices, ORLocate sponge X-ray detection, ORLocate Tag pull test, counting accuracy test, electromagnetic compatibility testing per IEC 60601-1-2:2007 and electrical safety testing per IEC 60601-1:1988 + A1:1991 + A2:1995 and EN 60601-1:1990 + A1:1993 + A2:1995 + A3:1996. The testing supports a determination of substantial equivalence to products and technologies previously cleared by FDA.
Key Metrics (Sensitivity, Specificity, PPV, NPV, etc.)
Not Found
Predicate Device(s)
Reference Device(s)
Not Found
Predetermined Change Control Plan (PCCP) - All Relevant Information
Not Found
§ 880.2740 Surgical sponge scale.
(a)
Identification. A surgical sponge scale is a nonelectrically powered device used to weigh surgical sponges that have been used to absorb blood during surgery so that, by comparison with the known dry weight of the sponges, an estimate may be made of the blood lost by the patient during surgery.(b)
Classification. Class I (general controls). The device is exempt from the premarket notification procedures in subpart E of part 807 of this chapter, subject to the limitations in § 880.9. The device also is exempt from the current good manufacturing practice requirements of the quality system regulation in part 820 of this chapter, with the exception of § 820.180, with respect to general requirements concerning records, and § 820.198, with respect to complaint files.
0
K10055 I
AUG 122 2010
IV. 510(K) SUMMARY
510(k) SUMMARY (21 CFR 807.92) ORLocate™ System
510(k) Owner:
Haldor Advanced Technologies Ltd. 2 Habanai st., Hod Hasharon, 45319 Israel Tel: +972 9 788 5867 Fax: +972 9 788 5861
Sarit Gal-Rom Gelbart Contact Person: Regulatory Consultant H.M.Da Consulting & Development Ltd. Tel +972 523 599 870 Email: sarit.gelbart@gmail.com
Or
Morr Avissara Product Manager Haldor Advanced Technologies Ltd. Tel: +972 52 868 5650 Email: morr.avissara@haldor-tech.com
Feb. 20th 2010 Date Prepared:
Name:
ORLocate™ System Trade Name:
Surgical Items Counting System Common:
Surgical sponge counter, Class I, 21 CFR 880.2740, LWH Classification
Nonabsorbable gauze for internal use, Class I, 21 CFR 878.4450, GDY
- Predicate Clearcount Medical SmartSponge K071355 RF Surgical Systems Inc. detection system, K062642 Devices: SurgiCount Medical, Inc. Safety-Sponge System, K060076
1
KIDOSS I 2/4
Device Description: Haldor ORLocate™ system is an RFID system providing a solution that enables the enumeration of sponges and surgical manual instruments, utilizing passive tags for keeping track of the items during surgery and to identify counting problems. In addition, the system provides a non-invasive means of locating retained surgical items within a surgical site.
The submission consists of the ORLocate™ system which includes: cart and antennas. Additionaly the submission includes accessories which are: associated single use surgical sponges, gauzes, pads and surgical towels each fitted with a uniquely coded RFID tag and uniquely coded RFID tag used for surgical instruments. The RF frequency the system uses is 13.56 MHz according to ISO 15693.
The system supplies also a semi-automatic application to help in counting untagged items, the count information is first entered manually and the calculations are automatic.
From this point on the system cart and antennas will be referred to as the "ORLocate™ system," sponges fitted with Haldor RFID tag will be referred to as "RFID tagged sponge" or "RFID tagged item" and a manual surgical instrument fitted with Haldor RFID tag will be referred to as "RFID tagged surgical instrument" or "RFID tagged item" too.
The system detects each RFID tagged item placed on top of the system antennas prior to surgery and creates an inventory of all sponges (e.g. gauzes, pads) and instruments. The user can also register new items during surgery and the inventory is updated automatically after the new items are scanned in an RFID antenna. The system performs automatic count of all inventory every 5 minutes and also performs count upon user request.
At the end of the procedure, final counts are provided by the system and in the case that any items are missing the mobile antenna may be used to search the surgical site for the retained RFID tagged item.
Intended Use:
The ORLocate™ system is indicated for use in recording and counting the number of RFID-tagged surgical sponges, laparotomy sponges, towels and other tagged items used during surgical procedures in which counting is required. In addition, the product is indicated for providing a non-invasive means of detecting retained RFID-tagged surgical sponges, towels and other tagged items within a surgical site, as an adjunctive detection method to current surgical counting systems and methods.
The indications are similar to those of the predicate device ClearCount SmartSponge system: "for use in counting and recording the number of RFID tagged surgical sponges, laparatomy sponges and towels used during surgical procedures." The
2
indications are also similar to those of the predicate device RF Surgical Systems Inc. Detection System: "intended to provide a non-invasive means of locating retained surgical sponges, gauze and other tagged items within a surgical site."
Technological Characteristics:
The ORLocate™ System is analogous to the predicate devices. Similar to the ClearCount SmartSponge System and the RF Surgical Systems Inc. Detection System, the system is comprised of a cart that contains the computer, processing units and connected antennas which can detect tags via a specific radio frequency signal. The tags are attached to surgical sponges and surgical instruments to enable the enumeration of the items. The RFID tag is securely sewn to each sponge, gauze or towel in the same manner as in the ClearCount SmartSponge System. A second type of RFID tag is securely attached to surgical instruments The mobile antenna in RF Surgical and the ORLocate™ system can read the tag signal through blood, bodily fluids and the body wall.
The customized software program, similar to the predicate software for the ClearCount SmartSponge System, uses the scanned and recorded information to count the number of items at the beginning of a surgical procedure, during and then again before surgical closure. A count can be obtained on demand from the computer and locates each item in antenna range. The count at the end of the surgery can be helpful in determining if any sponges are missing and may still be inside a patient.
Non-Clinical Performance Data:
Non-clinical testing included demonstrating performance of system and tagged items in laboratory tests. Tests demonstrated biocompatibility of tagged items, and permanent attachment of the tags to both sponges and instruments. The validated software functioned as intended under simulated use, properly counting sponges in body fluids. Test results also demonstrate the RFID tagged sponges and instruments are as safe as the predicate devices and the software installed on the system cart computer provides an added measure of safety and effectiveness to current methods of sponge and instrument counting presently used in the surgical and clinical environments. Pertinent testing done on this device include: system interference with operating room devices, ORLocate sponge X-ray detection, ORLocate Tag pull test, counting accuracy test, electromagnetic compatibility testing per IEC 60601-1-2:2007 and electrical safety testing per IEC 60601-1:1988 + A1:1991 + A2:1995 and EN 60601-1:1990 + A1:1993 + A2:1995 + A3:1996. The testing supports a determination of substantial equivalence to products and technologies previously cleared by FDA.
Conclusions:
the ORLocate system and accessories are In conclusion, substantially equivalent to the predicate devices identified. In addition, non-clinical performance data and test results demonstrate
3
the product is as safe and effective for its intended use as its predicate devices.
: ・
.
.
.
.
.
: 100 - 100 - 100 -
. .
·
:
.
・
4
DEPARTMENT OF HEALTH & HUMAN SERVICES
Image /page/4/Picture/1 description: The image shows the logo for the U.S. Department of Health & Human Services. The logo features a stylized eagle with its wings spread, along with the text "DEPARTMENT OF HEALTH & HUMAN SERVICES USA" arranged around the bird. The text is oriented in a circular fashion, with "DEPARTMENT OF HEALTH & HUMAN" on the left side and "SERVICES USA" on the right side.
Public Health Service
Food and Drug Administration 10903 New Hampshire Avenue Document Control Room -WO66-G609 Silver Spring, MD 20993-0002
Haldor Advanced Technologies, Ltd. % H.M.Da Consulting and Development Sarit Gelbart Gal-Rom 107 Shavey Tzion Pardes Hanna 37052 Israel
Re: K100551
Trade/Device Name: ORLocate™ system Regulation Number: 21 CFR 880.2740 -Regulation Name: Surgical sponge scale Regulatory Class: I Product Code: LWH Dated: June 17, 2010 Received: June 23, 2010
Dear Sarit Gelbart Gal-Rom:
We have reviewed your Section 510(k) premarket notification of intent to market the device referenced above and have determined the device is substantially equivalent (for the indications for use stated in the enclosure) to legally marketed predicate devices marketed in interstate commerce prior to May 28, 1976, the enactment date of the Medical Device Amendments, or to devices that have been reclassified in accordance with the provisions of the Federal Food. Drug. and Cosmetic Act (Act) that do not require approval of a premarket approval application (PMA). You may, therefore, market the device, subject to the general controls provisions of the Act. The general controls provisions of the Act include requirements for annual registration, listing of devices, good manufacturing practice, labeling, and prohibitions against misbranding and adulteration. Please note: CDRH does not evaluate information related to contract liability warranties. We remind you, however, that device labeling must be truthful and not misleading.
If your device is classified (see above) into either class I! (Special Controls) or class III (PMA), it may be subject to additional controls. Existing major regulations affecting your device can be found in the Code of Federal Regulations, Title 21, Parts 800 to 898. In addition, FDA may publish further announcements concerning your device in the Federal Register.
Please be advised that FDA's issuance of a substantial equivalence determination does not mean that FDA has made a determination that your device complies with other requirements of the Act or any Federal statutes and regulations administered by other Federal agencies. You must
AUG 12 2010
5
Page 2 - Sarit Gelbart Gal-Rom
comply with all the Act's requirements, including, but not limited to: registration and listing (21 CFR Part 807); labeling (21 CFR Part 801); medical device reporting (reporting of medical device-related adverse events) (21 CFR 803); good manufacturing practice requirements as set forth in the quality systems (QS) regulation (21 CFR Part 820): and if applicable, the electronic product radiation control provisions (Sections 531-542 of the Act); 21 CFR 1000-1050.
If you desire specific advice for your device on our labeling regulation (21 CFR Part 801), please go to http://www.fda.gov/AboutFDA/CentersOffices/CDRH/CDRHOffices/ucm115809.htm for the Center for Devices and Radiological Health's (CDRH's) Office of Compliance. Also, please note the regulation entitled, "Misbranding by reference to premarket notification" (21CFR Part 807.97). For questions regarding the reporting of adverse events under the MDR regulation (21 CFR Part 803), please go to
http://www.fda.gov/MedicalDevices/Safety/ReportaProblem/default.htm for the CDRH's Office of Surveillance and Biometrics/Division of Postmarket Surveillance.
You may obtain other general information on your responsibilities under the Act from the Division of Small Manufacturers, International and Consumer Assistance at its toll-free number (800) 638-2041 or (301) 796-7100 or at its Internet address
http://www.fda.gov/MedicalDevices/ResourcesforYou/Industry/default.htm.
Sincerely yours,
Mark A. Mellhess
Mark N. Melkerson Director Division of Surgical. Orthopedic and Restorative Devices Office of Device Evaluation Center for Devices and Radiological Health
Enclosure
6
INDICATIONS FOR USE STATEMENT III.
Indications for Use
AUG 122 2010
510(k) Number (if known): New Submission
Device Name: ORLocate™ system
Indication for use: The ORLocate™ system is indicated for use in recording and counting the number of RFID-tagged surgical sponges, laparotomy sponges, towels and other tagged items used during surgical procedures in which counting is required. In addition, the product is indicated for providing a non-invasive means of detecting retained RFID-tagged surgical sponges, towels and other tagged items within a surgical site, as an adjunctive detection method to current surgical counting systems and methods.
Prescription Use X (Part 21 CFR 801 Subpart D)
Over-The-Counter Use AND/OR (21 CFR 801 Subpart C)
(PLEASE DO NOT WRITE BELOW THIS LINE-CONTINUE ON ANOTHER PAGE OF NEEDED)
Concurrence of CDRH, Office of Device Evaluation (ODE)
Page 1 of 1
Daniel Knaefoeluxm
(Division Sign-Off)
Division of Surgical. Orthopedic, and Restorative Devices
510(k) Number K100551